Daily Palonosetron Is Superior to Ondansetron in the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients With Acute Myelogenous Leukemia

BACKGROUND: Nausea and vomiting in patients with acute myelogenous leukemia (AML) can be from various causes, including the use of high-dose cytarabine. METHODS: The authors compared 2 schedules of palonosetron versus ondansetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Mattiuzzi, Gloria N., Cortes, Jorge E., Blamble, Deborah A., Bekele, B. Nebiyou, Xiao, Lianchun, Cabanillas, Maria, Borthakur, Gautam, O’Brien, Susan, Kantarjian, Hagop
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185295/
https://ncbi.nlm.nih.gov/pubmed/21218459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25365
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items